Work LM - Search Results

1

Vascular bed-targeted in vivo gene delivery using tropism-modified adeno-associated viruses.

Work LM, Büning H, Hunt E, Nicklin SA, Denby L, Britton N, Leike K, Odenthal M, Drebber U, Hallek M, Baker AH. Work LM, et al. Mol Ther. 2006 Apr;13(4):683-93. doi: 10.1016/j.ymthe.2005.11.013. Epub 2006 Jan 4. Mol Ther. 2006. PMID: 16387552 Free article.

2

Ablating adenovirus type 5 fiber-CAR binding and HI loop insertion of the SIGYPLP peptide generate an endothelial cell-selective adenovirus.

Nicklin SA, Von Seggern DJ, Work LM, Pek DC, Dominiczak AF, Nemerow GR, Baker AH. Nicklin SA, et al. Among authors: work lm. Mol Ther. 2001 Dec;4(6):534-42. doi: 10.1006/mthe.2001.0489. Mol Ther. 2001. PMID: 11735337 Free article.

3

Use of phage display to identify novel peptides for targeted gene therapy.

Work LM, Nicklin SA, White SJ, Baker AH. Work LM, et al. Methods Enzymol. 2002;346:157-76. doi: 10.1016/s0076-6879(02)46055-7. Methods Enzymol. 2002. PMID: 11883067

4

Targeting gene therapy vectors to the vascular endothelium.

Work LM, Nicklin SA, Baker AH. Work LM, et al. Curr Atheroscler Rep. 2003 May;5(3):163-70. doi: 10.1007/s11883-003-0019-9. Curr Atheroscler Rep. 2003. PMID: 12667427 Review.

5

Gene Therapy for Cardiovascular Disease.

Dishart KL, Work LM, Denby L, Baker AH. Dishart KL, et al. Among authors: work lm. J Biomed Biotechnol. 2003;2003(2):138-148. doi: 10.1155/S1110724303209086. J Biomed Biotechnol. 2003. PMID: 12721517 Free PMC article.

6

Development of efficient viral vectors selective for vascular smooth muscle cells.

Work LM, Nicklin SA, Brain NJ, Dishart KL, Von Seggern DJ, Hallek M, Büning H, Baker AH. Work LM, et al. Mol Ther. 2004 Feb;9(2):198-208. doi: 10.1016/j.ymthe.2003.11.006. Mol Ther. 2004. PMID: 14759804 Free article.

7

Dual targeting of gene delivery by genetic modification of adenovirus serotype 5 fibers and cell-selective transcriptional control.

Work LM, Ritchie N, Nicklin SA, Reynolds PN, Baker AH. Work LM, et al. Gene Ther. 2004 Aug;11(16):1296-300. doi: 10.1038/sj.gt.3302292. Gene Ther. 2004. PMID: 15292916

8

Improved gene delivery to human saphenous vein cells and tissue using a peptide-modified adenoviral vector.

Work LM, Reynolds PN, Baker AH. Work LM, et al. Genet Vaccines Ther. 2004 Oct 8;2(1):14. doi: 10.1186/1479-0556-2-14. Genet Vaccines Ther. 2004. PMID: 15473900 Free PMC article.

9

Cell-selective viral gene delivery vectors for the vasculature.

Baker AH, Kritz A, Work LM, Nicklin SA. Baker AH, et al. Among authors: work lm. Exp Physiol. 2005 Jan;90(1):27-31. doi: 10.1113/expphysiol.2004.028126. Epub 2004 Nov 12. Exp Physiol. 2005. PMID: 15542621 Free article. Review.

10

Adenoviral serotype 5 vectors pseudotyped with fibers from subgroup D show modified tropism in vitro and in vivo.

Denby L, Work LM, Graham D, Hsu C, von Seggern DJ, Nicklin SA, Baker AH. Denby L, et al. Among authors: work lm. Hum Gene Ther. 2004 Nov;15(11):1054-64. doi: 10.1089/hum.2004.15.1054. Hum Gene Ther. 2004. PMID: 15610606

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters